Gender differences in pretreatment quality of life in a prospective lung cancer trial

Journal of Supportive Oncology

Volumn 6, Issue 1, 2008, Pages 33-39

  Siddiqui, Farzan ^a,b,c   Kohl, Robert ^a,b,c   Swann, Suzanne ^a,b,c   Watkins Bruner, Deborah ^a,b,c   Movsas, Benjamin ^a,b,c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; VINBLASTINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEX DIFFERENCE; TREATMENT RESPONSE; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEX FACTORS; TREATMENT OUTCOME;

EID: 38949154083     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics,2007. CA Cancer J Clin 2007;57:43-66. [17237035]
2. Bruner DW, Movsas B, Konski A, et al. Outcomes research in cancer clinical trial cooperative groups: the RTOG model. Qual Life Res 2004;13:1025-1041. [15287270]
3. Movsas B, Scott C. Quality-of-life trials in lung cancer: past achievements and future challenges. Hematol Oncol Clin North Am 2004;18:161-186. [15005287]
4. Harper P, Plunkett T, Khayat D. Quality trials and quality of life in non-small-cell lung cancer. J Clin Oncol 2003;21:3007-3008.[12837809]
5. Cella D. The Functional Assessment of Cancer Therapy-Lung and Lung Cancer Subscale assess quality of life and meaningful symptom improvement in lung cancer. Semin Oncol 2004;31 (3 suppl 9):11-15. [15206077]
6. Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997;33:1025-1030.[9376182]
7. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients:as an important prognostic factor. Lung Cancer 2001;31:233-240. [11165402]
8. Moinpour CM, Lyons B, Grevstad PK, et al. Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial. Qual Life Res 2002;11:115-126.[12018735]
9. Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol 2002;20:2920-2929.[12089220]
10. Heyes A. Clinical trial experience with Functional Assessment of Cancer Therapy-Lung in conventional and targeted non-small cell lung cancer therapy. Semin Oncol 2004;31(3 suppl 9):16-22. [152060781
11. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S.The prevalence of psychological distress by cancer site. Psychooncology 2001;10:19-28.[11180574]
12. Sarna L, Riedinger MS. Assessment of quality of life and symptom improvement in lung cancer clinical trials. Semin Oncol 2004;31 (3 suppl 9):1-10. [15293365]
13. Fuller TD, Edwards JN, Sermsri S, Vorakitphokatorn S. Gender and health: some Asian evidence. J Health Soc Behav 1993;34:252-271. [7989669]
14. Verbrugge LM.The twain meet: empirical explanations of sex differences in health and mortality. J Health Soc Behav 1989;30:282-304.[2778300]
15. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 2006;21:194-199. [16140507]
16. Greimel ER, Padilla GV, Grant MM. Gender differences in outcomes among patients with cancer. Psychooncology 1998;7:197-206.[9638781]
17. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.[8445433]
18. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984;2:472-483.[6374052]
19. Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 1988:11:630-633.[3055933]
20. Cella DF, Orofiamma B, Holland JC, et al. The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer 1987;60:1661-1667.[3621136]
21. Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 1991;67:3131-3135. [1710541]
22. Buccheri G. Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998;11:173-178.[9543289]
23. Ferguson MK, Skosey C, Hoffman PC, Golomb HM. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 1990;8:1402-1407.[2166143]
24. Visbal AL, Williams BA, Nichols FC 3rd, et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004;78:209-215; discussion 215.[15223430]
25. Patel JD. Lung cancer in women. J Clin Oncol 2005;23:3212-3218.[15886308]
26. Sarna L, Brown JK, Cooley ME, et al. Quality of life and meaning of illness of women with lung cancer. Oncol Nurs Forum 2005;32:E9-E19.[15660139]
27. Sarna L. Correlates of symptom distress in women with lung cancer. Cancer Pract 1993;1:21-28 [8324526]
28. Zebrack B. Cancer survivors and quality of life: a critical review of the literature. Oncol Nurs Forum 2000;27:1395-1401.[11058971]
29. Schmidt CE, Bestmann B, Kuchler T, Longo WE, Rohde V, Kremer B. Gender differences in quality of life of patients with rectal cancer:a five-year prospective study. World J Surg 2005;29:1630-1641.[16311851]
30. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345-1351. [114350631
31. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R. Quality of life assessment in clinical trials - guidelines and a checklist for protocol writers:the U.K. Medical Research Council experience. MRC Cancer Trials Office. Eur J Cancer 1997;33:20-28.[9071894]
32. Troxel AB, Fairclough DL, Curran D, Hahn EA. Statistical analysis of quality of life with missing data in cancer clinical trials. Stat Med 1998;17:653-666. [9549814]
33. Curran D, Molenberghs G, Fayers PM, Machin D. Incomplete quality of life data in randomized trials: missing forms. Stat Med 1998;17:697-709. [9549817]
34. Siddiqui F, Pajak TF, Watkins-Bruner D, et al. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients:a Radiation Therapy Oncology Group Analysis. Int J Radiat Oncol Biol Phys 2007 Sep 20. Epub ahead of print. [17889449]